phosphatidylcholines has been researched along with 8-isoprostaglandin e2 in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (8-isoprostaglandin e2) | Trials (8-isoprostaglandin e2) | Recent Studies (post-2010) (8-isoprostaglandin e2) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 68 | 4 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demer, LL; Effros, RB; Graham, LS; Kitchen, CM; Parhami, F; Tintut, Y | 1 |
1 other study(ies) available for phosphatidylcholines and 8-isoprostaglandin e2
Article | Year |
---|---|
Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.
Topics: Animals; Bone Density; Bone Resorption; Cell Nucleus; Dietary Fats; Dinoprostone; Gene Expression; Humans; Isoprostanes; Lipids; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoprotegerin; Oxidation-Reduction; Phosphatidylcholines; RANK Ligand; Scavenger Receptors, Class E; T-Lymphocytes; Transcription Factor RelA | 2009 |